Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Leukemia

  Free Subscription


Articles published in Eur J Haematol

Retrieve available abstracts of 80 articles:
HTML format
Text format



Single Articles


    August 2018
  1. LAM TS, van de Meent M, Marijt EWA, Falkenburg JHF, et al
    Immune surveillance by autoreactive CD4 positive helper T-cells is a common phenomenon in patients with acute myeloid leukemia.
    Eur J Haematol. 2018 Aug 4. doi: 10.1111/ejh.13157.
    PubMed     Text format     Abstract available


    July 2018
  2. HOEKS M, van der Pol M, Middelburg R, Evers D, et al
    Bone marrow iron score as an indicator for secondary iron overload in acute myeloid leukemia patients.
    Eur J Haematol. 2018 Jul 17. doi: 10.1111/ejh.13145.
    PubMed     Text format     Abstract available


  3. BOUVIER A, Ribourtout B, Francois S, Orvain C, et al
    Donor cell-derived acute promyelocytic leukemia after allogeneic hematopoietic stem cell transplantation.
    Eur J Haematol. 2018 Jul 14. doi: 10.1111/ejh.13143.
    PubMed     Text format     Abstract available


    June 2018
  4. JOFFE E, Goldschmidt N, Bairey O, Fineman R, et al
    Outcomes of Second-Line Treatment After Fludarabine Cyclophosphamide and Rituximab in Patients with Chronic Lymphocytic Leukemia Outside Clinical Trials.
    Eur J Haematol. 2018 Jun 27. doi: 10.1111/ejh.13129.
    PubMed     Text format     Abstract available


  5. LATAGLIATA R, Breccia M, Carmosino I, Cesini L, et al
    Clinical Results According to Age in Patients with Chronic Myeloid Leukemia Receiving Imatinib Frontline: the Younger, the Later, the Worse?
    Eur J Haematol. 2018 Jun 13. doi: 10.1111/ejh.13110.
    PubMed     Text format     Abstract available


    May 2018
  6. BALL S, Vutthikraivit W, Maiti A, Short NJ, et al
    Infection with Ibrutinib in patients with Chronic Lymphocytic Leukemia (CLL): How strong is the association?
    Eur J Haematol. 2018 May 23. doi: 10.1111/ejh.13098.
    PubMed     Text format     Abstract available


    April 2018
  7. OTA S, Matsukawa T, Yamamoto S, Shinichi I, et al
    Severe adverse events by tyrosine kinase inhibitors decrease survival rates in patients with newly diagnosed chronic phase chronic myeloid leukemia.
    Eur J Haematol. 2018 Apr 16. doi: 10.1111/ejh.13081.
    PubMed     Text format     Abstract available


  8. TIEN FM, Hou HA, Tsai CH, Tang JL, et al
    Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients.
    Eur J Haematol. 2018 Apr 6. doi: 10.1111/ejh.13073.
    PubMed     Text format     Abstract available


    March 2018
  9. PALMA M, Hansson L, Mulder TA, Adamson L, et al
    Lenalidomide as immune adjuvant to a dendritic cell vaccine in chronic lymphocytic leukemia patients.
    Eur J Haematol. 2018 Mar 23. doi: 10.1111/ejh.13065.
    PubMed     Text format     Abstract available


    February 2018
  10. ROBAK T, Blonski J, Skotnicki AB, Piotrowska M, et al
    Rituximab, cladribine and cyclophosphamide (RCC) induction with rituximab maintenance in chronic lymphocytic leukemia: PALG - CLL4 (ML21283) trial.
    Eur J Haematol. 2018 Feb 10. doi: 10.1111/ejh.13042.
    PubMed     Text format     Abstract available


  11. KHALIL MMI, Lipton JH, Atenafu EG, Gupta V, et al
    Impact of comorbidities constituting the hematopoietic cell transplant (HCT)-comorbidity index on the outcome of patients undergoing allogeneic HCT for acute myeloid leukemia.
    Eur J Haematol. 2018;100:198-205.
    PubMed     Text format     Abstract available


    January 2018
  12. BURILLO-SANZ S, Morales-Camacho RM, Caballero-Velazquez T, Carrillo E, et al
    MLL-rearranged acute myeloid leukemia: Influence of the genetic partner in allo-HSCT response and prognostic factor of MLL 3' region mRNA expression.
    Eur J Haematol. 2018 Jan 31. doi: 10.1111/ejh.13037.
    PubMed     Text format     Abstract available


  13. MURAI K, Yamaguchi K, Ito S, Miyagishima T, et al
    Rapid reduction in BCR-ABL1 transcript predicts deep molecular response in dasatinib-treated chronic-phase chronic myeloid leukaemia patients.
    Eur J Haematol. 2018;100:27-35.
    PubMed     Text format     Abstract available


    December 2017
  14. CUI W, Wang J, Nie RM, Zhao LL, et al
    Arsenic trioxide at conventional dosage does not aggravate hemorrhage in the first-line treatment of adult acute promyelocytic leukemia.
    Eur J Haematol. 2017 Dec 20. doi: 10.1111/ejh.13018.
    PubMed     Text format     Abstract available


  15. JAMROZIAK K, Szymczyk A, Hus M, Wojciechowska M, et al
    Hodgkin's variant of Richter's transformation during ibrutinib therapy in a series of CLL patients; the Polish Adult Leukemia Group report (PALG).
    Eur J Haematol. 2017 Dec 15. doi: 10.1111/ejh.13016.
    PubMed     Text format     Abstract available


  16. GONG X, Lin D, Wang H, Wang Y, et al
    Flow Cytometric Analysis of Cerebrospinal Fluid in Adult Patients with Acute Lymphoblastic Leukemia during Follow-Up.
    Eur J Haematol. 2017 Dec 14. doi: 10.1111/ejh.13011.
    PubMed     Text format     Abstract available


    November 2017
  17. LENGFELDER E, Gorlich D, Nowak D, Spiekermann K, et al
    Frontline therapy of acute promyelocytic leukemia: Randomized comparison of ATRA and intensified chemotherapy versus ATRA and anthracyclines.
    Eur J Haematol. 2017 Nov 7. doi: 10.1111/ejh.12994.
    PubMed     Text format     Abstract available


  18. COMBARIZA JF, Toro LF, Orozco JJ, Arango M, et al
    Cost-effectiveness analysis of interventions for prevention of invasive aspergillosis among leukemia patients during hospital construction activities.
    Eur J Haematol. 2017 Nov 6. doi: 10.1111/ejh.12991.
    PubMed     Text format     Abstract available


    October 2017
  19. GONSALVES WI, Buadi FK, Kumar SK
    Combination therapy incorporating Bcl-2 inhibition with Venetoclax for the treatment of refractory primary plasma cell leukemia with t (11;14).
    Eur J Haematol. 2017 Oct 24. doi: 10.1111/ejh.12986.
    PubMed     Text format     Abstract available


  20. DUPLOYEZ N, Abou Chahla W, Lejeune S, Marceau-Renaut A, et al
    Detection of a new heterozygous germline ETV6 mutation in a case with hyperdiploid acute lymphoblastic leukemia (ALL).
    Eur J Haematol. 2017 Oct 16. doi: 10.1111/ejh.12981.
    PubMed     Text format     Abstract available


  21. TULSTRUP M, Frandsen TL, Abrahamsson J, Lund B, et al
    Individualized 6-mercaptopurine increments in consolidation treatment of childhood acute lymphoblastic leukemia: a NOPHO randomized controlled trial.
    Eur J Haematol. 2017 Oct 6. doi: 10.1111/ejh.12979.
    PubMed     Text format     Abstract available


    September 2017
  22. KAYSER S, Feszler M, Krzykalla J, Schick M, et al
    Clinical Impact of KMT2C and SPRY4 Expression Levels in Intensively Treated Younger Adult Acute Myeloid Leukemia Patients.
    Eur J Haematol. 2017 Sep 22. doi: 10.1111/ejh.12972.
    PubMed     Text format     Abstract available


  23. SZARZYNSKA-ZAWADZKA B, Kosmalska M, Sedek L, Sonsala A, et al
    Cost-effective screening of DNMT3A coding sequence identifies somatic mutation in pediatric T-cell acute lymphoblastic leukemia.
    Eur J Haematol. 2017 Sep 14. doi: 10.1111/ejh.12964.
    PubMed     Text format     Abstract available


    August 2017
  24. ISHIKAWA C, Senba M, Hashimoto T, Imaizumi A, et al
    Expression and significance of Pim-3 kinase in adult T-cell leukemia.
    Eur J Haematol. 2017 Aug 19. doi: 10.1111/ejh.12940.
    PubMed     Text format     Abstract available


  25. PAPROCKA M, Bielawska-Pohl A, Rossowska J, Krawczenko A, et al
    MRP1 protein expression in leukemic stem cells as a negative prognostic marker in acute myeloid leukemia patients.
    Eur J Haematol. 2017 Aug 14. doi: 10.1111/ejh.12938.
    PubMed     Text format     Abstract available


  26. WANG W, Bochtler T, Wuchter P, Manta L, et al
    Mesenchymal stromal cells contribute to quiescence of therapy resistant leukemic cells in acute myeloid leukemia.
    Eur J Haematol. 2017 Aug 11. doi: 10.1111/ejh.12934.
    PubMed     Text format     Abstract available


    July 2017
  27. GEELEN IGP, Thielen N, Janssen JJWM, Levin MD, et al
    Influence of WHO versus ELN advanced phase chronic myeloid leukemia definitions on overall survival.
    Eur J Haematol. 2017 Jul 18. doi: 10.1111/ejh.12928.
    PubMed     Text format     Abstract available


    June 2017
  28. D'ARENA G, Vitale C, Perbellini O, Coscia M, et al
    Prognostic relevance of oxidative stress measurement In chronic lymphocytic leukemia.
    Eur J Haematol. 2017 Jun 24. doi: 10.1111/ejh.12918.
    PubMed     Text format     Abstract available


  29. NASILOWSKA-ADAMSKA B, Warzocha K, Solarska I, Borg K, et al
    BCRP mRNA and FLT3-ITD are independent poor risk factors in adult patients with acute myeloid leukemia and intermediate or normal karyotype.
    Eur J Haematol. 2017 Jun 15. doi: 10.1111/ejh.12913.
    PubMed     Text format     Abstract available


  30. PELLO OM, Innes AJ, Bradshaw A, Finn SA, et al
    BKV-specific T cells in the treatment of severe refractory haemorrhagic cystitis after HLA-haploidentical haematopoietic cell transplantation.
    Eur J Haematol. 2017;98:632-634.
    PubMed     Text format     Abstract available


    May 2017
  31. GLAVEY S, Quinn J, McCloy M, Sargent J, et al
    Emergence of Bruton's Tyrosine Kinase-negative Hodgkin Lymphoma During Ibrutinib Treatment of Chronic Lymphocytic Leukaemia.
    Eur J Haematol. 2017 May 31. doi: 10.1111/ejh.12911.
    PubMed     Text format     Abstract available


  32. NAHI H, Genell A, Walinder G, Uttervall K, et al
    Incidence, characteristics and outcome of solitary plasmacytoma and plasma cell leukemia. Population based data from the Swedish Myeloma Register.
    Eur J Haematol. 2017 May 22. doi: 10.1111/ejh.12907.
    PubMed     Text format     Abstract available


  33. KAWAMOTO K, Miyoshi H, Yanagida E, Yoshida N, et al
    Comparison of clinicopathological characteristics between T-cell prolymphocytic leukemia and peripheral T-cell lymphoma, not otherwise specified.
    Eur J Haematol. 2017;98:459-466.
    PubMed     Text format     Abstract available


    April 2017
  34. KOZLOWSKI P, Lennmyr E, Ahlberg L, Bernell P, et al
    Age but not Philadelphia positivity impairs outcome in older/elderly patients with acute lymphoblastic leukemia in Sweden.
    Eur J Haematol. 2017 Apr 18. doi: 10.1111/ejh.12896.
    PubMed     Text format     Abstract available


  35. LARFORS G, Sandin F, Richter J, Sjalander A, et al
    The impact of socio-economic factors on treatment choice and mortality in chronic myeloid leukaemia.
    Eur J Haematol. 2017;98:398-406.
    PubMed     Text format     Abstract available


  36. RAUTENBERG C, Nachtkamp K, Dienst A, Schmidt PV, et al
    Sorafenib and azacitidine as salvage therapy for relapse of FLT3-ITD mutated AML after allo-SCT.
    Eur J Haematol. 2017;98:348-354.
    PubMed     Text format     Abstract available


    March 2017
  37. ZADA M, Lerner D, Piltz Y, Perry C, et al
    Familial Chronic Lymphocytic Leukemia in Israel: A Disproportionate Distribution Among Ashkenazi Jews.
    Eur J Haematol. 2017 Mar 31. doi: 10.1111/ejh.12889.
    PubMed     Text format     Abstract available


  38. TAGHILOO S, Allahmoradi E, Tehrani M, Hossein-Nataj H, et al
    Frequency and functional characterization of Exhausted CD8+ T-cells in chronic lymphocytic leukemia.
    Eur J Haematol. 2017 Mar 17. doi: 10.1111/ejh.12880.
    PubMed     Text format     Abstract available


  39. NOLTE F, Mossner M, Jann JC, Nowak D, et al
    Concomitant MDS with isolated 5q deletion and MGUS: case report and review of molecular aspects.
    Eur J Haematol. 2017;98:302-310.
    PubMed     Text format     Abstract available


  40. AL-SAWAF O, Fischer K, Herling CD, Ritgen M, et al
    Alemtuzumab consolidation in chronic lymphocytic leukaemia: a phase I/II multicentre trial.
    Eur J Haematol. 2017;98:254-262.
    PubMed     Text format     Abstract available


    February 2017
  41. LAZAREVIC V, Rosso A, Juliusson G, Antunovic P, et al
    Incidence and prognostic significance of isolated trisomies in adult acute myeloid leukemia: a population-based study from the Swedish AML Registry.
    Eur J Haematol. 2017 Feb 2. doi: 10.1111/ejh.12861.
    PubMed     Text format     Abstract available


  42. SEKINE M, Kubuki Y, Kameda T, Takeuchi M, et al
    Effects of mogamulizumab in adult T-cell leukemia/lymphoma in clinical practice.
    Eur J Haematol. 2017 Feb 2. doi: 10.1111/ejh.12863.
    PubMed     Text format     Abstract available


  43. THOTA S, Advani A
    Inotuzumab ozogamicin in relapsed b-cell acute lymphoblastic leukemia.
    Eur J Haematol. 2017 Feb 2. doi: 10.1111/ejh.12862.
    PubMed     Text format     Abstract available


  44. GONZALEZ-GASCON Y MARIN I, Martin AA, Hernandez-Sanchez M, Robledo C, et al
    Hyperdiploidy as a rare event that accompanies poor prognosis markers in CLL.
    Eur J Haematol. 2017;98:142-148.
    PubMed     Text format     Abstract available


    January 2017
  45. MORI N, Ohwashi-Miyazaki M, Yoshinaga K, Okada M, et al
    Tumor suppressor gene methylation on the short arm of chromosome 1 in chronic myelogenous leukemia.
    Eur J Haematol. 2017 Jan 27. doi: 10.1111/ejh.12857.
    PubMed     Text format     Abstract available


  46. CAHU X, Carre M, Recher C, Pigneux A, et al
    Impact of body-surface area on patients' outcome in younger adults with acute myeloid leukemia.
    Eur J Haematol. 2017 Jan 25. doi: 10.1111/ejh.12850.
    PubMed     Text format     Abstract available


  47. SODERLUND S, Dahlen T, Sandin F, Olsson-Stromberg U, et al
    Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era - a report from the Swedish CML register.
    Eur J Haematol. 2017;98:57-66.
    PubMed     Text format     Abstract available


    December 2016
  48. FATHI AT, Chen YB
    The Role of FLT3 Inhibitors in the Treatment of FLT3 Mutated Acute Myeloid Leukemia.
    Eur J Haematol. 2016 Dec 21. doi: 10.1111/ejh.12841.
    PubMed     Text format     Abstract available


  49. ALGRIN C, Golmard JL, Michallet M, Reman O, et al
    Flow cytometry minimal residual disease after allogeneic transplant for chronic lymphocytic leukemia.
    Eur J Haematol. 2016 Dec 10. doi: 10.1111/ejh.12836.
    PubMed     Text format     Abstract available


    October 2016
  50. KRON F, Kutsch N, Kostenko A, Dohle I, et al
    Economic evaluation of Chronic Lymphatic Leukemia from a Hospital Management Perspective.
    Eur J Haematol. 2016 Oct 11. doi: 10.1111/ejh.12817.
    PubMed     Text format     Abstract available


  51. HEMMATI PG, Vuong LG, Terwey TH, Jehn CF, et al
    Predictive significance of the European LeukemiaNet classification of genetic aberrations in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation.
    Eur J Haematol. 2016 Oct 5. doi: 10.1111/ejh.12815.
    PubMed     Text format     Abstract available


    September 2016
  52. HEIBLIG M, Elhamri M, Jeune CL, Laude MC, et al
    Acute myeloid leukemia in the elderly (age 70 years or older): Long-term survivors.
    Eur J Haematol. 2016 Sep 26. doi: 10.1111/ejh.12811.
    PubMed     Text format     Abstract available


  53. SILLA L, Dulley F, Saboya R, Kerbauy F, et al
    Brazilian guidelines on HSCT in acute myeloid leukemia.
    Eur J Haematol. 2016 Sep 13. doi: 10.1111/ejh.12808.
    PubMed     Text format     Abstract available


  54. DEGWERT N, Latuske E, Vohwinkel G, Stamm H, et al
    Deoxycytidine kinase is downregulated under hypoxic conditions and confers resistance against cytarabine in acute myeloid leukaemia.
    Eur J Haematol. 2016;97:239-44.
    PubMed     Text format     Abstract available


    August 2016
  55. ROMBOUT A, Verhasselt B, Philippe J
    Lipoprotein lipase in chronic lymphocytic leukemia: function and prognostic implications.
    Eur J Haematol. 2016 Aug 9. doi: 10.1111/ejh.12789.
    PubMed     Text format     Abstract available


  56. HEHLMANN R
    CML - we are not there yet.
    Eur J Haematol. 2016;97:107.
    PubMed     Text format    


  57. KRISTENSEN L, Kristensen T, Abildgaard N, Royo C, et al
    LPL gene expression is associated with poor prognosis in CLL and closely related to NOTCH1 mutations.
    Eur J Haematol. 2016;97:175-82.
    PubMed     Text format     Abstract available


  58. THIELEN N, Visser O, Ossenkoppele G, Janssen J, et al
    Chronic myeloid leukemia in the Netherlands: a population-based study on incidence, treatment, and survival in 3585 patients from 1989 to 2012.
    Eur J Haematol. 2016;97:145-54.
    PubMed     Text format     Abstract available


    July 2016
  59. ANSARI J, Naqash AR, Munker R, El-Osta H, et al
    Histiocytic sarcoma as a secondary malignancy: pathobiology, diagnosis, and treatment.
    Eur J Haematol. 2016;97:9-16.
    PubMed     Text format     Abstract available


    May 2016
  60. MALMBERG EB, Stahlman S, Rehammar A, Samuelsson T, et al
    Patient-tailored analysis of minimal residual disease in acute myeloid leukemia using next generation sequencing.
    Eur J Haematol. 2016 May 20. doi: 10.1111/ejh.12780.
    PubMed     Text format     Abstract available


  61. GEISSLER K, Jager E, Barna A, Sliwa T, et al
    In vitro and in vivo effects of JAK2 inhibition in chronic myelomonocytic leukemia.
    Eur J Haematol. 2016 May 9. doi: 10.1111/ejh.12773.
    PubMed     Text format     Abstract available


  62. WOLF D, Mayer K
    When and how to 'FLAMSA-RIC' in acute myeloid leukemia?
    Eur J Haematol. 2016;96:445-6.
    PubMed     Text format    


  63. HOLTICK U, Shimabukuro-Vornhagen A, Chakupurakal G, Theurich S, et al
    FLAMSA reduced-intensity conditioning is equally effective in AML patients with primary induction failure as well as in first or second complete remission.
    Eur J Haematol. 2016;96:475-82.
    PubMed     Text format     Abstract available


    April 2016
  64. SCHMOHL JU, Nuebling T, Wild J, Kroell T, et al
    RANK-L expression on blasts in patients with acute myeloid leukemia is associated with survival, PD-1/PD-1L expression has no impact.
    Eur J Haematol. 2016 Apr 20. doi: 10.1111/ejh.12762.
    PubMed     Text format     Abstract available


    March 2016
  65. SAINI L, Brandwein J, Turner R, Larratt L, et al
    The FLAG Chemotherapy Regimen Is an Alternative to Anthracycline Based Therapy for the Treatment of Acute Myeloid Leukemia for Patients with Pre-Existing Cardiac Disease.
    Eur J Haematol. 2016 Mar 29. doi: 10.1111/ejh.12757.
    PubMed     Text format     Abstract available


  66. SARANG Z, Gyurina K, Scholtz B, Kiss C, et al
    Altered expression of autophagy-related genes might contribute to glucocorticoid resistance in precursor B-cell type acute lymphoblastic leukemia.
    Eur J Haematol. 2016 Mar 7. doi: 10.1111/ejh.12753.
    PubMed     Text format     Abstract available


    February 2016
  67. BARON F, Nagler A
    Best allogeneic transplantation approach for AML patients in first CR: is delayed unrelated donor bone marrow transplantation better than immediate unrelated cord blood transplantation?
    Eur J Haematol. 2016 Feb 10. doi: 10.1111/ejh.12745.
    PubMed     Text format     Abstract available


  68. GUNNARSSON N, Sandin F, Hoglund M, Stenke L, et al
    Population-based assessment of chronic myeloid leukemia in Sweden: striking increase in survival and prevalence.
    Eur J Haematol. 2016 Feb 2. doi: 10.1111/ejh.12743.
    PubMed     Text format     Abstract available


  69. DAHLEN T, Kalin M, Cederlund K, Nordlander A, et al
    Decreased invasive fungal disease but no impact on overall survival by posaconazole compared to fluconazole prophylaxis: a retrospective cohort study in patients receiving induction therapy for acute myeloid leukaemia/myelodysplastic syndromes.
    Eur J Haematol. 2016;96:175-80.
    PubMed     Text format     Abstract available


    January 2016
  70. LIM SJ, Lim MJ, Raptis A, Hou JZ, et al
    Outcome of acute myeloid leukemia patients with pulmonary nodules of uncertain etiology receiving allogeneic hematopoietic progenitor cell transplant.
    Eur J Haematol. 2016;96:55-9.
    PubMed     Text format     Abstract available


  71. GENTILE M, Cutrona G, Molica S, Ilariucci F, et al
    Prospective validation of predictive value of abdominal computed tomography scan on time to first treatment in Rai 0 chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study.
    Eur J Haematol. 2016;96:36-45.
    PubMed     Text format     Abstract available


    December 2015
  72. YANADA M, Kanda J, Ohtake S, Fukuda T, et al
    Unrelated bone marrow transplantation or immediate umbilical cord blood transplantation for patients with acute myeloid leukemia in first complete remission.
    Eur J Haematol. 2015 Dec 18. doi: 10.1111/ejh.12723.
    PubMed     Text format     Abstract available


  73. BASSAN R, Maino E, Cortelazzo S
    Lymphoblastic lymphoma: an updated review on biology, diagnosis and treatment.
    Eur J Haematol. 2015 Dec 17. doi: 10.1111/ejh.12722.
    PubMed     Text format     Abstract available


  74. MAURER C, Pflug N, Bahlo J, Kluth S, et al
    Bendamustine and Rituximab in Combination with Lenalidomide in Patients with Chronic Lymphocytic Leukemia.
    Eur J Haematol. 2015 Dec 8. doi: 10.1111/ejh.12714.
    PubMed     Text format     Abstract available


  75. TAMARA S, Irina S, Alexey B, Nataliya P, et al
    The Ability of Multipotent Mesenchymal Stromal Cells from the Bone Marrow of Patients with Leukemia to Maintain Normal Hematopoietic Progenitor Cells.
    Eur J Haematol. 2015 Dec 8. doi: 10.1111/ejh.12713.
    PubMed     Text format     Abstract available


    July 2015
  76. OSTENDORF BN, Terwey TH, Hemmati PG, Bohmer D, et al
    Severe radiotoxicity in an allogeneic transplant recipient with a heterozygous ATM mutation.
    Eur J Haematol. 2015;95:90-2.
    PubMed     Text format     Abstract available


    June 2015
  77. PULTE D, Redaniel MT, Bird J, Jeffreys M, et al
    Survival for patients with chronic leukemias in the US and Britain: Age-related disparities and changes in the early 21st century.
    Eur J Haematol. 2015;94:540-5.
    PubMed     Text format     Abstract available


    May 2015
  78. LAZAREVIC V, Horstedt AS, Johansson B, Antunovic P, et al
    Failure matters: unsuccessful cytogenetics and unperformed cytogenetics are associated with a poor prognosis in a population-based series of acute myeloid leukaemia.
    Eur J Haematol. 2015;94:419-23.
    PubMed     Text format     Abstract available


  79. SCOPIM-RIBEIRO R, Machado-Neto JA, Campos Pde M, Silva CA, et al
    Ten-eleven-translocation 2 (TET2) is downregulated in myelodysplastic syndromes.
    Eur J Haematol. 2015;94:413-8.
    PubMed     Text format     Abstract available


    April 2015
  80. FALK IJ, Willander K, Chaireti R, Lund J, et al
    TP53 mutations and MDM2(SNP309) identify subgroups of AML patients with impaired outcome.
    Eur J Haematol. 2015;94:355-62.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: